Edition:
United Kingdom

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,482JPY
25 Apr 2019
Change (% chg)

¥-38 (-2.53%)
Prev Close
¥1,520
Open
¥1,503
Day's High
¥1,522
Day's Low
¥1,476
Volume
7,061,300
Avg. Vol
6,304,922
52-wk High
¥2,056
52-wk Low
¥1,356

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 26.60 March 25 Apr 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 5 6 7 7
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.60 2.83 2.85 2.85

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 1 300,900.00 300,900.00 300,900.00 --
Quarter Ending Dec-19 1 339,900.00 339,900.00 339,900.00 --
Year Ending Mar-19 9 1,300,870.00 1,316,800.00 1,280,000.00 1,293,560.00
Year Ending Mar-20 9 1,241,640.00 1,274,200.00 1,196,000.00 1,270,710.00
Earnings (per share)
Quarter Ending Sep-19 1 26.60 26.60 26.60 --
Quarter Ending Dec-19 1 35.76 35.76 35.76 --
Year Ending Mar-19 10 113.46 127.08 101.80 97.02
Year Ending Mar-20 10 102.54 125.70 85.58 88.70
LT Growth Rate (%) 2 4.57 9.40 -0.26 0.05

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-18 359,208.00 357,932.00 1,276.34 0.36
Quarter Ending Sep-18 325,808.00 318,011.00 7,796.66 2.39
Quarter Ending Jun-18 320,417.00 329,085.00 8,668.00 2.71
Quarter Ending Mar-18 303,365.00 300,873.00 2,491.66 0.82
Quarter Ending Dec-17 350,011.00 359,689.00 9,678.00 2.77

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 300,900.00 300,900.00 300,800.00 300,800.00 --
Quarter Ending Dec-19 339,900.00 339,900.00 339,900.00 339,900.00 --
Year Ending Mar-19 1,300,870.00 1,300,870.00 1,303,720.00 1,300,940.00 1,293,560.00
Year Ending Mar-20 1,241,640.00 1,241,640.00 1,250,510.00 1,265,420.00 1,270,710.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 0 1 0
Quarter Ending Dec-19 0 0 0 0
Year Ending Mar-19 0 0 0 1
Year Ending Mar-20 0 0 0 1
Earnings